Page last updated: 2024-08-23

cefazolin and Peripheral Vascular Diseases

cefazolin has been researched along with Peripheral Vascular Diseases in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
AbuRahma, AF; Campbell, JR; Emmett, M; Hass, SM; Modak, A; Mousa, AY; Nanjundappa, A; Srivastiva, M; Stone, PA1
Bader, MS; Hawboldt, J; Twells, L1
Hoaglund, PA; Shoultz, DA; Tice, AD1
Goldman, L1
Jones, MJ; Kerins, CA; Peek, TE; Ross, CB; Wheeler, WG1

Trials

2 trial(s) available for cefazolin and Peripheral Vascular Diseases

ArticleYear
Prospective randomized double-blinded trial comparing 2 anti-MRSA agents with supplemental coverage of cefazolin before lower extremity revascularization.
    Annals of surgery, 2015, Volume: 262, Issue:3

    Topics: Adult; Aged; Antibiotic Prophylaxis; Cefazolin; Chi-Square Distribution; Daptomycin; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lower Extremity; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Patient Safety; Peripheral Vascular Diseases; Preoperative Care; Prospective Studies; Radiography; Risk Assessment; Staphylococcal Infections; Surgical Wound Infection; Treatment Outcome; Vancomycin; Vascular Surgical Procedures

2015
Ceftriaxone versus cefazolin in peripheral arterial operations: a randomized, prospective trial.
    Southern medical journal, 1997, Volume: 90, Issue:1

    Topics: Aged; Aged, 80 and over; Antibiotic Prophylaxis; Arteries; Cefazolin; Ceftriaxone; Cephalosporins; Female; Humans; Incidence; Male; Middle Aged; Peripheral Vascular Diseases; Prospective Studies; Reoperation; Risk Factors; Surgical Wound Infection

1997

Other Studies

3 other study(ies) available for cefazolin and Peripheral Vascular Diseases

ArticleYear
Risk factors of cellulitis treatment failure with once-daily intravenous cefazolin plus oral probenecid.
    Southern medical journal, 2011, Volume: 104, Issue:12

    Topics: Administration, Oral; Anti-Bacterial Agents; Cefazolin; Cellulitis; Chi-Square Distribution; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Logistic Models; Male; Middle Aged; Peripheral Vascular Diseases; Probenecid; Retrospective Studies; Risk Factors; Treatment Failure; Veins

2011
Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy.
    The American journal of medicine, 2003, Jun-15, Volume: 114, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Amputation, Surgical; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Child; Diabetes Complications; Female; Humans; Infusions, Intravenous; Male; Medical Records; Middle Aged; Osteomyelitis; Outcome Assessment, Health Care; Penicillins; Peripheral Vascular Diseases; Proportional Hazards Models; Recurrence; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Vancomycin; Washington

2003
Overlapping publications.
    The American journal of medicine, 2003, Dec-15, Volume: 115, Issue:9

    Topics: Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Diabetes Mellitus; Duplicate Publications as Topic; Humans; Osteomyelitis; Penicillins; Peripheral Vascular Diseases; Staphylococcal Infections

2003